Flexion Therapeutics Inc
Drug Manufacturers-Specialty & Generic
Healthcare
FLXN
49.97M shares
NASDAQ US
traded
18 Nov 2021
open
9.14
52 week high
13.09
high
9.23
52 week low
4.40
low
9.12
growth
-15.71%
previous Close
9.14
P/E ratio
-21
market cap
313M
div yield
0
usd
Jun 2021
qoq
revenue
28.18M
14.58 %
net incoming
-22.21M
22.23 %
eps
-0.44
22.81 %
eps surprise
12.00 %
net profit margin
-78.82 %
37.00 %
operating incoming
-16.88M
27.05 %
net change in cash
8.92M
199.17 %
cash on hand
108M
9.04 %
cost of revenue
4.98M
-18.18 %
top top